| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $176.5M | $274.2M | $302.0M |
| YoY Revenue Growth % | -35.6% | -9.2% | — |
| Gross Profit | $18.4M | $27.3M | — |
| Gross Margin % | 10.4% | 10.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.6M | -$7.8M | $1.2M |
| Operating Margin % | -2.0% | -2.8% | 0.4% |
| Net Income (GAAP) | -$14.9M | -$24.3M | -$12.7M |
| EBITDA (Normalized) | -$3.1M | -$6.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $356.0K | $23.5M | $33.3M |
| Capital Expenditures (CapEx) | $517.0K | $1.8M | — |
| Free Cash Flow (FCF) | -$161.0K | $21.7M | $33.3M |
| FCF Margin % | -0.1% | 7.9% | 11.0% |
| Return on Invested Capital (ROIC %) | -28.2% | -45.0% | — |
| Cash & Short-Term Equivalents | $14.3M | $12.2M | — |
| Total Debt (Short + Long Term) | $17.6M | $13.1M | — |
| Total Stockholders' Equity | $6.7M | $5.3M | — |